Open AccessS‐222611, an oral reversible tyrosine kinase inhibitor of EGFR and HER2. A representative histological image of the colon treated with S‐222611 (25 mg/kg)
Author(s) -
Tanaka Hidekazu,
Hirata Michinari,
Shiome Satomi,
Wada Toru,
Iguchi Motofumi,
Dohi Keiji,
Inoue Makiko,
Ishioka Yukichi,
Hojo Kanji,
Yamada Tomomi,
Sugimoto Tatsuya,
Masuno Koichi,
Nezasa Kenichi,
Sato Norihito,
Matsuo Kenji,
Yonezawa Shuji,
Frenkel Eugene P.,
Shichijo Michitaka
Publication year - 2014
Publication title -
cancer science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.035
H-Index - 141
eISSN - 1349-7006
pISSN - 1347-9032
DOI - 10.1111/cas.12481
Subject(s) - medicine